2008
DOI: 10.1080/14756360701511292
|View full text |Cite
|
Sign up to set email alerts
|

Advances in assays of matrix metalloproteinases (MMPs) and their inhibitors

Abstract: Matrix metalloproteinases (MMPs) play an important role in many physiological and pathological processes. To assay the activities of MMPs is important in diagnosis and therapy of the MMPs associated diseases, such as neoplastic, rheumatic and cardiovascular diseases. Several assay systems have been developed, which include bioassay, zymography assay, immunoassay, fluorimetric assay, radio isotopic assay, phage-displayed assay, multiple-enzyme/multiple-reagent assay and activity-based profiling assay. The princ… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
21
1
1

Year Published

2008
2008
2023
2023

Publication Types

Select...
4
2
2

Relationship

0
8

Authors

Journals

citations
Cited by 29 publications
(23 citation statements)
references
References 109 publications
0
21
1
1
Order By: Relevance
“…Examining MMP activity is significant in the diagnosis and therapy of diseases associated with MMPs -i.e., illnesses of the salivary glands and skin [34].…”
Section: Methodsmentioning
confidence: 99%
“…Examining MMP activity is significant in the diagnosis and therapy of diseases associated with MMPs -i.e., illnesses of the salivary glands and skin [34].…”
Section: Methodsmentioning
confidence: 99%
“…Immunochemical methods precede enzymatic methods, but cannot distinguish between active MMP and inactive MMP in zymogene form [9]. Fluorimetric methods using fluorescent-labelled substrates show low detection limits but allow to determine MMP activity quantitatively and to study target MMP sequences [10]. There are a number of other methods that are subjects of interest such as phage display, Multiple-Enzyme/Multiple-Reagent Assay System (MEMRAS) and activity-based profiling including reversed zymography.…”
mentioning
confidence: 99%
“…MMPs can be used as markers for some cancers including colorectal, thyroid, bladder and breast cancer, neurodegenerative, immune and cardiovascular diseases [8]. Assays for the detection of MMPs for both clinical and research purposes are summarized in the following reviews [9][10][11][12][13].…”
mentioning
confidence: 99%
“…For many MPs, the nature of the assays available limits their use for the testing of a large number of compounds because of high volume requirements, low sensitivity, and constraints of time and cost. 22 Based on our previous findings, we speculated that we could address this major issue by turning the nonspecific MP inhibitor actinonin into a universal probe for MPs. Our results show that in fact it is the case, and an FP probe based on an analog of actinonin bound to 16 of the 24 MPs tested and provided a sufficient signal window for a robust assay ( Table 2).…”
Section: Discussionmentioning
confidence: 99%